Collaborations

Completion of research phase of product development collaboration announced

Published in Gene Therapy Weekly, October 20th, 2005

Large Scale Biology Corporation (LSBC) and Icon Genetics (ICON) announced the successful completion of the research phase of their collaborative program to co-develop a biopharmaceutical product for enzyme replacement therapy and the initiation of the commercial phase of the collaboration.

The alliance has focused on the synergistic application of LSBC's and ICON's patented gene expression and biomanufacturing resources with the goal of developing and commercializing a product for enzyme replacement therapy, the manufacture of which by conventional technologies has proven difficult and expensive.

Both ICON and LSBC biomanufacture their own and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2005-10-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry